Cargando…
Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedin...
Autores principales: | El Kawkgi, Omar M., Li, Dingfeng, Kotwal, Anupam, Wermers, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749243/ https://www.ncbi.nlm.nih.gov/pubmed/33367219 http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006 |
Ejemplares similares
-
Hypoparathyroidism: an uncommon adverse effect of treatment with durvalumab
por: Kreze, Alexander, et al.
Publicado: (2022) -
Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up
por: Dadu, Ramona, et al.
Publicado: (2020) -
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
por: Trinh, Beckey, et al.
Publicado: (2019) -
A Patient with Hyperthyroidism and An Anterior Mediastinal Mass
por: Li, Dingfeng, et al.
Publicado: (2020) -
Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes
por: Kotwal, Anupam, et al.
Publicado: (2019)